Today: 14 May 2026

Gold price stock today: GLD steadies after wild swing as Fed minutes, margin hike keep traders cautious

Gold price stock today: GLD steadies after wild swing as Fed minutes, margin hike keep traders cautious

Gold rebounded 0.8% to $4,364.70 an ounce Tuesday after plunging 4.47% Monday, as thin year-end trading fueled volatility. The SPDR Gold Shares ETF edged up 0.1%, and gold miners steadied. CME Group raised margin requirements for precious-metals futures. Investors await Wednesday’s U.S. jobless claims and the final trading session of 2025.
Bitcoin price stock today: BTC ticks up near $88,000 as Fed minutes and ETF flows set the tone

Bitcoin price stock today: BTC ticks up near $88,000 as Fed minutes and ETF flows set the tone

Bitcoin rose 1.1% to about $88,243 in late U.S. trading Tuesday, after spot bitcoin ETFs saw $19.3 million in net outflows led by BlackRock and Invesco funds, Farside data showed. Strategy disclosed buying 1,229 bitcoin for $108.8 million last week. Coinbase slipped 0.9% after hours, while crypto miners Marathon Digital and Riot Platforms dropped. The dollar held gains after Fed minutes signaled policy uncertainty.
Silver price today: SLV pops after-hours as spot silver rebounds from record-high whiplash

Silver price today: SLV pops after-hours as spot silver rebounds from record-high whiplash

iShares Silver Trust (SLV) jumped 4.5% to $68.98 in after-hours trading Tuesday, tracking a rebound in spot silver, which rose 5.4% to $76.20 an ounce. The move followed Monday’s record high of $83.62 and sharpest drop since 2020. CME raised futures margin requirements after the close Dec. 29. Investors watched Fed signals and geopolitical tensions as trading remained volatile.
Dow Jones today: DJIA slips after Fed minutes; Boeing pops on $8.6B Pentagon deal

Dow Jones today: DJIA slips after Fed minutes; Boeing pops on $8.6B Pentagon deal

The Dow Jones Industrial Average fell 94.87 points, or 0.2%, to 48,367.06 in thin after-hours trading Tuesday as investors digested Fed minutes and year-end positioning. Boeing rose nearly 2% after an $8.6 billion Pentagon contract, while declines in Goldman Sachs and Home Depot weighed on the index. Meta Platforms agreed to buy AI startup Manus in a deal reportedly worth up to $3 billion. Citigroup flagged a $1.2 billion pre-tax loss on its Russian unit sale.
Meta’s Manus AI deal lifts META as S&P 500 slips in thin year-end trade; Fed minutes in focus

Meta’s Manus AI deal lifts META as S&P 500 slips in thin year-end trade; Fed minutes in focus

The S&P 500 fell 0.14%, Nasdaq lost 0.23%, and the Dow slipped 0.20% in thin post-holiday trading. Meta rose 1.1% after announcing it will acquire AI startup Manus, boosting communication services. Fed minutes showed policymakers split over December’s rate cut. Citigroup dropped 0.8% after revealing a $1.2 billion pre-tax loss tied to the sale of its Russian unit.
Coinbase stock dips after-hours as Needham slashes target, flags weak crypto volumes

Coinbase stock dips after-hours as Needham slashes target, flags weak crypto volumes

Coinbase shares fell about 0.9% in after-hours trading Tuesday after Needham cut its price target to $290 from $400, citing weak crypto trading volumes. Clear Street said Coinbase could benefit if prediction markets grow, projecting the market could reach $14 billion by 2030. Bitcoin rose 1.4% Tuesday, while other crypto stocks slipped. Coinbase remains below key moving averages after a sharp pullback from 2025 highs.
Sandisk stock today: SNDK slips after-hours as company sets Jan. 29 earnings date

Sandisk stock today: SNDK slips after-hours as company sets Jan. 29 earnings date

Sandisk shares fell 1.6% to $240.22 in after-hours trading Tuesday after the company set its fiscal Q2 earnings call for Jan. 29, 2026. Micron and Western Digital also slipped, while the semiconductor ETF was little changed. Sandisk stock has surged about 594% in 2025. The company last reported Q1 revenue of $2.31 billion and forecast Q2 revenue of $2.55–$2.65 billion.
Ekso Bionics stock nearly doubles as Applied Digital cloud deal points to ChronoScale pivot

Ekso Bionics stock nearly doubles as Applied Digital cloud deal points to ChronoScale pivot

Ekso Bionics shares closed up 94% at $10.58 after announcing a deal outline to combine Applied Digital’s cloud unit with EKSO. Applied Digital would own about 97% of the merged company, leaving EKSO holders with roughly 3% before any deal financing, according to a filing. The stock’s market value reached about $36 million. Traders await definitive terms and SEC filings.
AST SpaceMobile stock rises today after insider-buy filing as options heat up on BlueBird rollout

AST SpaceMobile stock rises today after insider-buy filing as options heat up on BlueBird rollout

AST SpaceMobile shares rose 4.3% to $74.68 in after-hours trading Tuesday after a regulatory filing showed director Keith R. Larson bought 625 shares at $80 each under a pre-set plan. Nasdaq reported heavy options activity, led by $80 strike calls expiring Jan. 2. The company last week launched its BlueBird 6 satellite, aiming to deliver 4G and 5G directly to standard smartphones. AT&T said beta satellite service is planned for early next year.
30 December 2025
Exxon Mobil stock edges up after-hours as oil holds steady and energy sector leads year-end trade

Exxon Mobil stock edges up after-hours as oil holds steady and energy sector leads year-end trade

Exxon Mobil shares rose 0.4% to $120.99 in after-hours trading Tuesday, as energy stocks outperformed despite a slight drop in the broader market. Brent crude settled at $61.92 a barrel, little changed after recent volatility tied to Russia-Ukraine and Middle East tensions. The S&P 500 slipped 0.14%. Trinidad and Tobago approved a seismic survey for Exxon’s local unit.
Eli Lilly stock ticks up after hours as China price cuts put Mounjaro, Wegovy in focus

Eli Lilly stock ticks up after hours as China price cuts put Mounjaro, Wegovy in focus

Eli Lilly shares edged up 0.1% after hours to $1,079.75 following news it and Novo Nordisk are cutting prices on top obesity drugs in China. Novo confirmed Wegovy price reductions; a hospital WeChat post showed Mounjaro’s 10mg pen dropping to 445 yuan ($63) from 2,180 yuan. Novo’s U.S. shares slipped about 0.5%. Lilly Endowment Inc. disclosed selling 3,593 shares in a regulatory filing.
AppLovin stock slips after Fed minutes as year-end tech rotation hits APP shares

AppLovin stock slips after Fed minutes as year-end tech rotation hits APP shares

AppLovin shares fell 0.8% to $693.71 in after-hours trading Tuesday, following a session marked by wide swings and thin volume. The drop came as U.S. stocks edged lower after Federal Reserve minutes revealed divisions over interest rate policy. AppLovin is up about 121% year-to-date but remains volatile ahead of its expected mid-February earnings report. The S&P 500 slipped 0.14%, while the Nasdaq lost 0.23%.

Stock Market Today

  • Nanjing Leads Biolabs (SEHK:9887) Faces Valuation Challenges Amid Share Price Volatility
    May 14, 2026, 2:53 AM EDT. Nanjing Leads Biolabs, a clinical-stage biotech focused on antibody drugs, saw its shares drop 8% in one day and 12% over the past week despite a strong 3-month and year-to-date rally. The stock closed at HK$69.40, valuing the company at roughly HK$13.8 billion. Recent declines reflect investor caution over growth prospects and clinical pipeline risks. The discounted cash flow (DCF) model estimates an intrinsic value of HK$18.62 per share, far below current prices, suggesting the stock is trading at a steep premium. As the company posts revenue growth but still reports a net loss of CN¥211.419 million, further volatility is likely. Investors should watch pipeline progress closely, given the risk that elevated losses and delayed commercialization could trigger a correction.

Latest articles

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 14.05.2026

14 May 2026
LIVEMarkets rolling coverageStarted: May 14, 2026, 12:00 AM EDTUpdated: May 14, 2026, 2:53 AM EDT Nanjing Leads Biolabs (SEHK:9887) Faces Valuation Challenges Amid Share Price Volatility May 14, 2026, 2:53 AM EDT. Nanjing Leads Biolabs, a clinical-stage biotech focused on antibody drugs, saw its shares drop **8% in one day** and **12% over the past week** despite a strong 3-month and year-to-date rally. The stock closed at HK$69.40, valuing the company at roughly HK$13.8 billion. Recent declines reflect investor caution over growth prospects and clinical pipeline risks. The **discounted cash flow (DCF) model** estimates an intrinsic value of HK$18.62 per
Enovix Stock Drops After Q1 Beat as Smartphone Battery Tests Stay Unfinished

Enovix Stock Drops After Q1 Beat as Smartphone Battery Tests Stay Unfinished

14 May 2026
Enovix shares dropped 12.9% to $6.35 after hours Wednesday despite beating first-quarter revenue and adjusted-loss estimates. The decline followed news that smartphone battery qualification remains unfinished, with the company passing 72 of 75 customer tests. Revenue rose 49% to $7.6 million. Enovix cited progress in defense, industrial, and smart-eyewear sales.
Lightwave Logic Stock Jumps as AI-Photonics Bet Heads for a 2027 Production Test

Lightwave Logic Stock Jumps as AI-Photonics Bet Heads for a 2027 Production Test

14 May 2026
Lightwave Logic reported Q1 revenue up 27% to $29,000 and a net loss widening to $6.3 million. Shares rose 14% after the company said it is negotiating a supply and licensing deal for high-volume production in 2027. Four Fortune 500 customers are now in Stage 3 prototyping. Cash and equivalents totaled about $100 million as of May 11.
Go toTop